Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report.
Year: 2013
Type: article
Study design: Observational Study
Source: PubMed
Authors: Giuseppe Di Bella, Fabrizio Mascia, Alessandro Ricchi, Biagio Colori
Institution: Istituto Ortopedico Rizzoli
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2129837658
